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The lack of a well-behaved permanent, adherent, nontransformed chicken cell line has made some experiments with avian
leukosis–sarcoma viruses (ASLV) and vectors considerably more difficult. The EV-O-derived line, DF-1, supports the efficient
replication of subgroups (A), (B), and (C) ASLV, as well as amphotrophic murine leukemia virus and an ASLV-derived vector
that has its env gene derived from the env gene from an amphotrophic murine leukemia virus. The cell line responds
appropriately to the expression of a transforming oncogene (v-myc) to a growth suppressor gene [p21(waf1)] and can be
sorted (using FACS) if infected by an ASLV vector that expresses GFP. © 1998 Academic Press
INTRODUCTION
Although research with viruses and vectors of the
avian sarcoma–leukemia virus (ASLV) group has had a
long and successful history, the lack of a permanent,
adherent, nontransformed cell line that could be used to
prepare viral stocks and assay the effects of viral infec-
tion (i.e., transformation) has been a significant handi-
cap. Traditionally, ASLVs (and vectors derived from these
viruses) have been grown on chicken embryo fibroblasts
(CEFs). These cells, like all normal diploid fibroblasts,
have a finite life span (CEF can be grown for ;25–30
passages). Although the fact that these cells are entirely
normal has advantages for certain experiments (see, for
example, Givol et al., 1995, 1998), there are experiments
for which a cell line, particularly a nontransformed cell
line, would be most helpful.
Although it is possible to use QT6 (a transformed quail
line) for some ASLV experiments, this line is not ideal.
First, it is derived from a methyl cholanthrene-induced
tumor and is, as a consequence, highly transformed.
Second, because the QT6 cell line is derived from Japa-
nese quail (Coturnix coturnix japonica), it cannot be in-
fected by subgroup (B) ASLV and most subgroup (C)
ASLV infect QT6 inefficiently (Moscovici et al., 1977). If
subgroup (A) ASLV are used to infect QT6 cells, the initial
infection is relatively efficient; however, subgroup (A)
ASLV replicates relatively slowly on QT6 cells, and al-
though the precise results depend on the exact viral
strain used, fully infected QT6 cultures usually produce
viral titers that are 10–100-fold lower than the titers that
can be obtained when CEF are infected in parallel with
the same virus (unpublished observations). The well
characterized chicken cell lines are not suitable hosts for
most experiments with ASLV. Some of the available
chicken cell lines are transformed by ASLV, and the
Marek’s disease virus transformed T cell lines grow in
suspension culture, which makes them unsuitable for a
number of standard viral assays. It is possible to substi-
tute turkey embryo fibroblasts for some experiments, and
although these cells will grow longer in culture than CEF,
this only postpones, but does not solve, the underlying
problem.
We report here that the continuous, nontransformed
chicken cell line, DF-1, has the properties needed for use
with ASLV vectors and viruses. This line was derived in
culture from cells from EV-O embryos (Foster et al., in
preparation). As a consequence, it does not have any
endogenous viruses that are closely related to the ASLV
group of exogenous viruses. The absence of any closely
related endogenous viruses makes the analysis of infec-
tion, both by nucleic acid methods (Southern and North-
ern) and by protein methods (Westerns and ELISA), sim-
ple and accurate. It also means that the potential prob-
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lems associated with recombination with endogenous
viruses should be rare. Some sublines of DF-1 have been
passaged ;200 times. DF-1 cells are not transformed
and will undergo morphological transformation if in-
fected by an ASLV carrying most oncogenes that cause
morphological transformation in CEF. The response of
DF-1 to transforming oncogenes is more fully docu-
mented in the article by Himly et al. (1998)). DF-1 cells
support the efficient replication of ASLV of the (A), (B),
and (C) subgroups, as well as amphotrophic murine
leukemia virus (MLV) and an ASLV-derived vector,
RCASBP(M2C), that replicates using an amphotrophic
MLV envelope.
RESULTS
DF-1 cells permit the efficient replication of
subgroups (A), (B), and (C) ASLV
Culture conditions for DF-1 are similar to CEF (see
Materials and Methods); however, DF-1 cells will grow at
much lower densities than CEF and can be single-cell
cloned relatively easily. The origin and properties of DF-1
cells will be described in more detail elsewhere (Foster
et al., in preparation). The same calcium phosphate
transfection procedure (see Materials and Methods) was
used to introduce RCASBP(A)/AP, RCASBP(B)/AP, and
RCASBP(C)/AP into parallel cultures of EV-O-derived CEF
and DF-1. RCASBP is a replication competent ASLV vec-
tor (Federspiel and Hughes, 1997); AP is the gene for a
heat stable alkaline phosphatase that makes it conve-
nient to score infected cells and titer the viruses (Fields-
Berry et al., 1992; Fekete and Cepko, 1993). In experi-
ments of this sort, virus can usually be detected either by
a reverse transcriptase assay (Hughes et al., 1987) or by
ELISA using a polyclonal antibody against CA two cell
passages after transfection; most cultures are fully in-
fected by two or three cell passages after transfection. To
monitor the efficiency of DF-1 as a virus producer, the
titer of the RCASBP(A)/AP, produced in parallel by DF-1
and CEF, was measured on CEF. The titer of the virus
produced by DF-1 was ;2-fold higher than the titer of the
same virus produced by CEF, suggesting that DF-1 is a
slightly better virus producer than CEF (Table 1). To test
the efficiency of DF-1 as a target for viral infection, these
same viral stocks were used to infect DF-1 cells. In these
assays the titer was ;5-fold higher on DF-1, suggesting
that DF-1 is not only a better virus producer but also a
better target for subgroup (A) viruses than are EV-O CEF.
We also tested the ability of DF-1 cells to produce high
tiers of RCASBP(B)/AP and RCASBP(C)/AP. The titers of
the subgroup (B) and (C) viruses were ;1 log lower than
were the titers of the subgroup (A) virus and, in contrast
to the data with the subgroup (A) viruses, were similar on
CEF and DF-1. Subgroup (B) viruses are somewhat cyto-
toxic, and both the CEF cultures and the DF-1 cultures
that produced high levels of subgroup (B) virus showed
signs of this cytotoxic effect. (The cytotoxic effects of
these viruses are described by Himly et al. (1998)) The
degree of cytotoxicity is related to the level of expression
of the Env glycoprotein. As might be expected from this,
RCASBP(B) vectors usually cause obvious cytotoxicity;
the effects of RCAS(B) vectors are usually much more
subtle and may be missed (data not shown). Although
the EV-O CEF producing the subgroup (C) virus did not
show any obvious signs of cytotoxicity, DF-1 cells in-
fected with RCASBP(C) did show some signs of cytotox-
icity, and these cells, like the cells infected with the
RCASBP(B) virus, grew more slowly than uninfected DF-1
cells or DF-1 cells infected with subgroup (A) viruses.
To confirm the results obtained with the AP viruses,
some of the experiments were repeated with viruses that
express green fluorescent protein (GFP). Similar titers were
obtained with the AP and GFP viruses (see Table 1). We
also tested the titers of RCAS vectors. As expected, the
titers of RCAS on DF-1 cells are ;10–15-fold lower than the
titers of RCASBP; this difference is similar to what has been
seen with CEF (Federspiel and Hughes, 1997).
DF-1 cells respond to both Myc and p21waf1
DF-1 cells have a morphology that is similar to normal
CEF and are contact inhibited; however, DF-1 cells do not
show as much long range organization in culture as do
TABLE 1




RCASBP(A)/AP CEF 1 3 106 6 3 106
RCASBP(A)/AP DF-1 2 3 106 1 3 107
RCASBP(B)/AP DF-1 3 3 105 5 3 105
RCASBP(C)/AP DF-1 1 3 105 1 3 105
RCASBP(A)/GFP DF-1 1 3 107
RCASBP(C)/GFP DF-1 5 3 105
RCAS(A)/AP DF-1 6 3 105
RCAS(B)/AP DF-1 4 3 104
RCAS(C)/AP DF-1 4 3 104
Titer (S1L2)
MLV (4070A) CEF 3 3 105
MLV (4070A) DF-1 4.5 3 105
Note. ASLV virus stocks were produced either on DF-1 cells or on
CEF, frozen at 280°C, thawed, and then titered. Uninfected DF-1 or CEF
were infected with serial dilutions of the ASLV virus stocks, grown for
2 days, and fixed with 4% paraformaldehyde. The cells infected with the
AP viruses were assayed for AP activity (Federspiel and Hughes, 1997)
and counted. The cells infected with the GFP viruses were counted
directly by fluorescence microscopy. MLV stocks were titered using the
S1L2 assay (Bassin et al., 1971). The results shown are the averages
of representative duplicate assays.
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CEF, and the individual cells have a slightly blockier
appearance at high density. We tested how they would
respond both to an oncogene (v-myc) that will transform
CEF (Petropoulos et al., 1996) and to a growth suppres-
sor gene (waf1) that blocks the replication of CEF (Givol
et al., 1995, 1998). DF-1 cells were transfected with plas-
mids containing the genomes of RCASBP(A), RCASBP(A)/
v-myc, and RCASBP(B)/p21. Cells infected with the
RCASBP(A) virus showed no detectable morphological
alterations; cells infected with RCASBP(A)/v-myc were
obviously transformed, and infection with RCASBP(B)/
p21 caused the growth arrest of DF-1 cells (see Fig. 1). In
these experiments, DF-1 cells behave similarly to CEF
and are a convenient substitute.
DF-1 cells support the replication of amphotrophic
MLV and the amphotrophic ASLV vector
RCASBP(M2C)
Amphotrophic MLV will replicate on both CEF and
DF-1 cells (Table 1). We developed a replication-compe-
tent ASLV vector, RCASBP(M2C), by replacing the enve-
lope gene of the parental ASLV with the env gene of the
amphotrophic MLV (4070A). The resulting vector was
adapted to replicate efficiently on CEF, a process that
involved selection for a point mutant in the env gene
(Barsov and Hughes, 1996). The vector replicates to
high titers on CEF and efficiently infects, but does
not replicate in, mammalian cells. The adapted virus
RCASBP(M2C) also replicates efficiently in DF-1 cells.
However, although the RCASBP(M2C) virus replicates
well in DF-1 cells, it is cytotoxic. Syncitia can be seen in
infected cultures, and a substantial fraction of the cells
develop cytoplasmic vacuoles that are not seen in the
uninfected controls (Fig. 2). This is the expected result;
RCASBP(M2C) is also cytotoxic in CEF. To make it easy
to monitor infection with the RCASBP(M2C) vector, the
GFP gene was subcloned into the vector. The resulting
vector, RCASBP(M2C)/GFP, was introduced into DF-1
cells using the standard transfection protocol.
The amount of GFP (and the intensity of the green
color) varied from cell to cell (Fig. 3). This is presumably
due to the effects of the integration site on the level of
FIG. 1. Effect of v-Myc and p21waf1 on DF-1 cells. (Top) Normal DF-1
cells. The appearance of cells infected by RCASBP(A) is indistinguishable
from uninfected DF-1. (Middle) DF-1 cells infected by RCASBP(A)/v-myc.
Cells were transfected (see Materials and Methods) with a plasmid that
encodes the v-Myc-expressing virus. After one or two passages, trans-
formed cells appeared in the culture; by passage 3, the entire culture was
transformed. The photograph shows cells three passages after transfec-
tion. (Bottom) DF-1 cells infected with RCASBP(B)/p21. Cells were trans-
fected with a plasmid that encodes the p21waf1-expressing virus. Two
passages after transfection, the cells stopped dividing. These nondividing
cells are shown in C. Magnification, 1003.
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expression of individual proviruses. The green color can
be easily seen using a standard fluorescent microscope
and measured quantitatively using a fluorescence acti-
vated cell sorter (FACS). FACS analysis showed that
95–99% of the infected DF-1 cells expressed sufficient
GFP to be differentiated from uninfected cells (Fig. 4). If
the infected DF-1 cells were sorted into populations that
expressed either high or low levels of GFP, the level of
expression was stable, which is consistent with (but
does not prove) that it is the site of integration that
determines the level of GFP expression (data not shown).
RCASBP(M2C)/GFP will infect mammalian cells effi-
ciently, and an FACS machine can be used to select
infected mammalian cells, and if it is desired for a par-
ticular experiment, single cells expressing GFP can be
obtained (data not shown).
DISCUSSION
Although it has been possible to use CEF to do
experiments with ASLV vectors and viruses, the lack of
a stable, nontransformed chicken cell line has been a
handicap for certain experiments. We believe that the
DF-1 cell line provides a reasonable solution to this
problem. Because this cell line is derived from an EV-O
embryo, it does not contain any endogenous provi-
ruses that are closely related to the ASLV viruses.
DF-1, which is nontransformed, responds appropri-
ately to oncogenic transformation by v-Myc, and its
replication is blocked by p21waf1. This should make the
DF-1 line, together with suitably chosen transforming
retroviruses, a useful tool for investigating oncogenic
transformation. This is discussed more extensively in
the article by Himly et al. (1998).
ASLV viruses and, by extension, the RCAS vectors
are available with several different env subgroups,
which makes it possible to introduce two or more
genes to test whether their products interact. This
procedure has been quite useful in experiments with
CEF. Because the RCAS vectors are replication com-
petent, the viruses spread rapidly and routinely pro-
duce cultures in which essentially all of the cells
express two (or more) proteins of interest. We used
FIG. 2. Effect of RCASBP(M2C) on DF-1 cells. (Left) Uninfected DF-1 cells at low and high magnification (1003 and 2003, respectively). (Right) DF-1
cells infected with RCASBP(M2C). (Top) At low magnification, syncitia. (Bottom) At high magnification, the cells have distinct cytoplasmic vacuoles.
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this system to monitor the interaction or interactions of
Bcl2 and Myc and to consider whether p21waf1 is able
to block the replication of CEF infected with any one of
several oncogenes (Givol et al. 1995, 1998). Others
have used this system to measure the interaction or
interactions of other proteins. Because this procedure
is both simple and powerful, we wanted to show that,
like CEF, DF-1 cells could also be infected by several
different env subgroups. The cell line can be readily
infected by subgroup (A), (B), and (C) ASLVs and sup-
ports the efficient replication of viruses of these three
env subgroups. CEF from the EV-O line of chickens,
which were used to prepare DF-1 are C/E. Although
we did not test DF-1 directly, we would expect that they
could not be infected with subgroup (E) ASLV. How-
ever, the cDNA for a functional subgroup (E) receptor
has recently been cloned (Adkins et al., 1997), and this
cDNA should make it a simple matter to prepare de-
rivates of DF-1 that can support the replication of
subgroup (E) ASLV.
As expected, infection with subgroup (A) viruses did
not cause significant cytopathic effects, but subgroup (B)
viruses, which are cytopathic in CEF, were also cyto-
pathic on DF-1. What was unexpected was that subgroup
(C) viruses, which are not normally cytopathic on CEF,
were cytopathic on DF-1 cells. At the moment, we do not
have an explanation for this result.
Amphotrophic MLV will grow on CEF, and on DF-1
cells as well. In addition, both CEF and DF-1 cells sup-
port the efficient replication of the RCASBP(M2C) vector;
however, as is true on CEF, RCASBP(M2C) does cause
cytopathic effects and syncytia on DF-1 cells. Because
GFP is a convenient marker, some tests of vector repli-
cation and behavior were done with an RCASBP(M2C)
vector that expresses GFP. As was true for the RCASBP
vectors that carry the subgroup (A), (B), and (C) env
genes, the RCASBP(M2C) vector expresses sufficiently
high levels of GFP that its expression can be monitored
either microscopically or using FACS.
It is convenient, with a permanent cell line like DF-1, to
prepare single-cell clones that carry a defined provirus
and express high titers of virus. However, if the virus is
FIG. 3. Cells infected by RCASBP(M2C)/GFP can be detected microscopically. DF-1 cells were infected with RCASBP(M2C)/GFP and were viewed
with a confocal microscope (magnification, 1003).
309AVIAN CELL LINE DF-1 SUPPORTS ASLV REPLICATION
cytopathic, like RCASBP(M2C), the highest titers are ob-
tained two or three passages after transfection, just as
the infection spreads to essentially all of the cells in the
culture. The highest titers are usually obtained either just
before, or at, the peak of the cytopathic effect. Although
it is possible to carry these cultures through the period of
crisis and, if so desired, to prepare single-cell clones that
express infectious virus, the titers obtained from these
cell clones are usually lower, and often much lower, than
the titers seen at the peak of the cytopathic effect. We
believe, although we have no direct evidence, that the
cells that express the highest levels of viral proteins are
also those cells that show the most significant cytopathic
effects. We believe that these cells are lost from the
culture by passage (or cloning) and what remains are
cells that express lower levels of viral proteins and, as a
consequence, produce lower viral titers.
It should be clear that in addition to the cytotoxic
effects caused by certain env genes (e.g., the amphotro-
phic env gene), the high level expression of certain
cellular genes can also have deleterious effects on the
growth of infected cells, both CEF and DF-1. Although it
is certainly possible to use both CEFs and DF-1s to
produce viral stocks that carry and express such genes
(e.g., waf1), it must be remembered that the high level
expression of such genes is subject to a strong negative
selection in cell culture. As such, it is inappropriate (and
usually impossible) to try to prepare cell lines that ex-
press high levels of such genes; in addition, repeated
passage of viral stocks that carry and express such
genes will usually result in the loss of expression of the
gene of interest.
Because DF-1 supports the efficient replication of ASLV
vectors, and because it lacks closely related endogenous
viruses, it should also be quite useful in the construction of
packaging lines that produce high titers of defective ASLV
vectors. So far, most such ASLV packaging lines have been
based on QT6 cells, and it seems quite likely that the
relatively poor replication efficiency of the ASLVs on QT6
cells contributes to the relatively poor titers obtained with
the QT6-derived packaging lines.
MATERIALS AND METHODS
Cell culture
Both CEF and DF-1 were grown in Dulbecco’s modified
Eagle’s medium supplemented with 5% calf serum, 5% fetal
calf serum and 10% tryptose phosphate broth, 100 U of
penicillin/ml, and 100 mg of streptomycin/ml (Federspiel
and Hughes, 1997) or in Dulbecco’s modified Eagle’s me-
dium supplemented with 10% fetal calf serum, 100 U of
penicillin/ml, and 100 mg of streptomycin/ml. Ordinarily,
both CEF and DF-1 are passaged using Trypsin-DeLarco
(Quality Biological, Inc., Gaithersburg, Maryland) by splitting
1:3 when the cultures are confluent, usually every 2 days. In
contrast to CEF, which grow poorly if plated at low density,
DF-1 will tolerate splitting at 1:5 or 1:10, and single-cell
cloning of DF-1 is relatively easy.
FIG. 4. DF-1 cells infected by RCASBP(M2C)/GFP can be fractionated in a cell sorter. Uninfected DF-1 cells and a parallel culture infected with
RCASBP(M2C)/GFP were fractionated on a cell sorter; .95% of the cells in the infected culture could be separated from uninfected cells by cell
sorting.
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Retroviral vectors
All of the vectors used in these experiments are
derivatives of the RCAS family (Hughes et al., 1987;
Petropoulos et al., 1991; Federspiel and Hughes, 1997).
RCAS-BP (Bryan Polymerase) was prepared from
RCAS by replacing the pol region with the correspond-
ing segment from the Bryan high titer strain of Rous
sarcoma virus (Federspiel and Hughes, 1997). The
subgroup A env gene from RCASBP(A) was replaced
with the subgroup C env gene from Prague C using the
plasmid pLC154 (a gift from J. A. T. Young). The 1.1-kb
Asp718/EcoRI fragment containing most of the sub-
group C env gene was ligated to an 882-bp EcoRI/ClaI
fragment and a 9.6-kb Asp718/ClaI fragment from
RCASBP(A). The resulting plasmid is RCASBP(C). The
RCASBP vectors grow to higher titers than the RCAS
vectors; the expression of an inserted gene is concom-
itantly higher in RCASBP. RCASBP(M2C) was prepared
by replacing the (A) envelope of RCASBP(A) with the
envelope coding region from an amphotrophic MLV
and then transfecting the resulting DNA onto CEF,
allowing the virus to grow and molecularly cloning the
adapted viruses (Barsov and Hughes, 1996).
RCAS (or RCASBP) vectors expressing p21(waf1), v-
myc, and AP have been described (Givol et al., 1995;
Petropoulos et al., 1996; Federspiel and Hughes, 1997).
GFP was converted into a ClaI fragment using the adap-
tor plasmid ClaI2Nco; this ClaI fragment was then in-
serted into the RCASBP vectors at the ClaI site.
DNA preparation and transfection
DNA was prepared for transfection using Qiagen col-
umns. DNA was introduced into cultured CEF and DF-1
using a standard CaPO4 transfection protocol (Hughes et
al., 1987; Federspiel and Hughes, 1997).
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